Venus Concept Receives FDA 510(k) Clearance of Venus BlissMAX for Non-Invasive Lipolysis of the Abdomen and Flanks, Cellulite Reduction and Muscle ConditioningGlobeNewsWire • 01/18/22
Venus Concept Inc. (VERO) CEO Dom Serafino on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/12/21
Venus Concept Announces Third Quarter and First Nine Months of 2021 Financial Results; Updates Fiscal Year 2021 Revenue GuidanceGlobeNewsWire • 11/12/21
Venus Concept (VERO) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 11/05/21
Venus Concept to Release Third Quarter of Fiscal Year 2021 Financial Results on November 12, 2021GlobeNewsWire • 10/04/21
Venus Concept Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/07/21
Venus Concept Inc. (VERO) CEO Dom Serafino on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/13/21
Venus Concept Announces Second Quarter 2021 Financial Results; Increases Fiscal Year 2021 Revenue GuidanceGlobeNewsWire • 08/13/21
Will Venus Concept (VERO) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 08/06/21
Venus Concept: Pandemic And Debt Obscure Promise Of Medical Aesthetics BusinessSeeking Alpha • 07/31/21
Venus Concept Announces Health Canada Authorization and CE Mark for Venus Fiore® Feminine Health SystemGlobeNewsWire • 07/20/21
Venus Concept Inc. to Participate in the Ladenburg Thalmann Healthcare Conference on July 13thGlobeNewsWire • 07/12/21
Venus Concept to Release Second Quarter of Fiscal Year 2021 Financial Results on August 13, 2021GlobeNewsWire • 07/08/21
Venus Concept Inc. (VERO) CEO Domenic Serafino on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/18/21